| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 924,600 | 791,700 | 757,300 | 718,500 | | Cost of Revenue | 502,900 | 472,700 | 455,000 | 434,300 | | | Gross Profit | 421,700 | 319,000 | 302,300 | 284,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 238,300 | 201,500 | 212,900 | 193,900 | | Non Recurring | 5,500 | 900 | 6,800 | 500 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 177,900 | 116,600 | 82,600 | 89,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 600 | 100 | 1,200 | 500 | | Earnings Before Interest And Taxes | 178,500 | 116,700 | 83,800 | 90,300 | | Interest Expense | 12,600 | 12,700 | 13,100 | 14,400 | | Income Before Tax | 165,900 | 104,000 | 70,700 | 75,900 | | Income Tax Expense | 55,800 | 32,000 | 23,800 | 21,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 116,300 | 82,100 | 43,700 | 57,700 | | | Non-recurring Events | | Discontinued Operations |
-
| (7,000) | 7,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 116,300 | 75,100 | 50,700 | 57,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $116,300 | $75,100 | $50,700 | $57,700 |
|
1.52% Nasdaq 0.00%
Income Statement
